History
  • No items yet
midpage
338 A.3d 1272
Del.
2025
Read the full case

Background

  • Jason Terrell, M.D., provided consulting services and served on the board of Kiromic Biopharma, Inc. between 2014 and 2021.
  • Terrell received three stock option awards under separate agreements: one for consulting (Agreement 1, 2014) and two for board service (Agreement 2, 2017; Agreement 3, 2017).
  • After resigning from the board in 2019, Terrell attempted to exercise options under Agreements 1 and 2, but Kiromic refused, relying on a waiver clause in Agreement 3.
  • Terrell sued for specific performance, claiming rights to the earlier options; the Court of Chancery dismissed his claim, finding a clear waiver in Agreement 3.
  • On appeal, the Delaware Supreme Court reviewed whether the contractual waiver language was ambiguous regarding the survival of earlier options.
  • The Court ultimately found ambiguity in the waiver language, reversed the dismissal, and remanded for further proceedings.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether the waiver in Agreement 3 unambiguously extinguished rights to options in Agreements 1 and 2 Terrell: Waiver is ambiguous; "securities…issued" includes prior granted options; language is susceptible to multiple meanings Kiromic: Waiver clearly covers all prior options; "issued" refers only to shares, not options Waiver language is ambiguous; both interpretations are reasonable; dismissal improper

Key Cases Cited

  • Salamone v. Gorman, 106 A.3d 354 (Del. 2014) (addresses the objective theory of contract interpretation and review of contract ambiguity)
  • Osborn ex rel. Osborn v. Kemp, 991 A.2d 1153 (Del. 2010) (discusses the objective theory of contracts in Delaware)
  • Manti Holdings, LLC v. Authentix Acquisition Co., Inc., 261 A.3d 1199 (Del. 2021) (clarifies when contract language is considered ambiguous)
  • Kuhn Const. Inc. v. Diamond State Port Corp., 990 A.2d 393 (Del. 2010) (sets out de novo standard of review for contract interpretation)
Read the full case

Case Details

Case Name: Terrell v. Kiromic Biopharma, Inc.
Court Name: Supreme Court of Delaware
Date Published: Jan 21, 2025
Citations: 338 A.3d 1272; 131, 2024
Docket Number: 131, 2024
Court Abbreviation: Del.
Log In
    Terrell v. Kiromic Biopharma, Inc., 338 A.3d 1272